USPTO serial 77364597
EXCEEDING YOUR EXPECTATIONS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 27, 2009
- Examiner
- CAPSHAW, DANIEL
- Law office
- GENERIC WEB UPDATE
What this means
Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.
Need help with EXCEEDING YOUR EXPECTATIONS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
ALLPHASE CLINICAL RESEARCH SERVICES INC.
OTTAWA, ON, CA
Other trademarks owned by ALLPHASE CLINICAL RESEARCH SERVICES INC.
Allphase Clinical Research (US), Inc.
Wilmington, DE, US
Other trademarks owned by Allphase Clinical Research (US), Inc.
Allphase Clinical Research (US), Inc.
Wilmington, DE, US
Other trademarks owned by Allphase Clinical Research (US), Inc.
Allphase Clinical Research (US), Inc.
Wilmington, DE, US
Other trademarks owned by Allphase Clinical Research (US), Inc.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mary Margaret L. O'Donnell
Mary Margaret L. O'Donnell Blue Filament Law PLLC772 E. Maple RoadBirmingham, MI 48009United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Pre-clinical to phase four clinical trial management services, namely, pre-study document collection and review, site selection, visits and audits, site compliance, project tracking and monitoring reports, negotiation and administration of investigator grants, labeling, packaging, distribution, coordination and tracking of clinical trial products and materials, regulatory document processing, central laboratory selection and coordination; pre-clinical to phase four clinical trial management services, namely, managing site and study-specific subject recruitment strategies and programs in the nature of contingency strategies and solutions to address specific project challenges; pre-clinical to phase four clinical trial management services, namely, managing the development of all study related documents and materials in the nature of study protocols, amendments, paper and electronic case report forms, informed consent forms, diary cards, safety narratives, presentation posters, technical briefs and training manuals; pre-clinical to phase four clinical trial management services, namely, managing all aspects of study, drug reconciliation, and inventory and distribution reports, managing all aspects of clinical trials, namely, managing investigators, technicians, and participants, ethical reviews, investigator meetings, databases, statistical analyses and reporting, randomization logistics, medical writing services, recruitment of investigators, technicians and participants; providing data management services in the medical, pharmaceutical and biotechnological field | ACTIVE | Feb 28, 2007 |
| 039 | Clinical supply storage in the field of clinical and medical supplies | ACTIVE | Feb 28, 2007 |
| 041 | Providing training in the field of clinical trials and clinical trial management for the pharmaceutical and biotechnological industries | ACTIVE | Feb 28, 2007 |
| 042 | Medical and scientific research consulting regarding pre-clinical to phase four clinical trials; providing quality assurance services in the pharmaceutical and biotechnological industries | ACTIVE | Feb 28, 2007 |
| 045 | Regulatory affairs, namely, reviewing standards and practices to assure compliance with clinical trial laws and regulations | ACTIVE | Feb 28, 2007 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ALLPHASE CLINICAL RESEARCH SERVICES INC.
- Other trademarks owned by Allphase Clinical Research (US), Inc.
- Other trademarks owned by Allphase Clinical Research (US), Inc.
- Other trademarks owned by Allphase Clinical Research (US), Inc.
- Other trademarks in Class 035
- Other trademarks in Class 039
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named EXCEEDING YOUR EXPECTATIONS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 13, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 13, 2026 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Aug 13, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 13, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 29, 2020 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Dec 11, 2019 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Dec 11, 2019 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Dec 11, 2019 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Dec 11, 2019 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 28, 2019 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Oct 27, 2018 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| May 25, 2017 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 1, 2015 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Oct 1, 2015 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Oct 1, 2015 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 27, 2015 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Oct 27, 2009 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 24, 2009 | REGV | LAW OFFICE REGISTRATION REVIEW COMPLETED | — |
| Sep 24, 2009 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Sep 11, 2009 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Sep 8, 2009 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Aug 11, 2009 | IUAF | USE AMENDMENT FILED | — |
| Aug 11, 2009 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Feb 17, 2009 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 25, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 5, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Oct 17, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 17, 2008 | ALIE | ASSIGNED TO LIE | — |
| Oct 3, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 3, 2008 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 3, 2008 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 3, 2008 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 3, 2008 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 2, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 2, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 2, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 4, 2008 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 4, 2008 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 4, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 3, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 8, 2008 | NWAP | NEW APPLICATION ENTERED | — |